Colorectal Cancer

>

Latest News

Biweekly TAS-102 Reduces Toxicity, Maintains Survival in Metastatic CRC
Biweekly TAS-102 Reduces Toxicity, Maintains Survival in Metastatic CRC

June 17th 2025

A retrospective analysis shows that trifluridine/tipiracil with or without bevacizumab given biweekly was favorable in those with colorectal cancer.

In patients 39 years and younger, a statistically significant association between colorectal cancer diagnosis and endometriosis was not observed.
Adverse Sexual Health Outcomes Appear More Likely in Women With CRC

June 12th 2025

Counseling received prior to colorectal surgery using 3-dimensional–printed anatomic models reduced mean anxiety scores vs conventional counseling.
Preoperative Counseling Increases Shared Decision-Making in CRC Surgery

June 11th 2025

Novel Therapy Yields Anti-Tumor Activity in KRAS G12C–Mutated CRC
Novel Therapy Yields Anti-Tumor Activity in KRAS G12C–Mutated CRC

May 31st 2025

Emergent alteration patterns were similarly diverse across treatment arms in the phase 3 CodeBreaK 300 study.
Genomic Alterations May Cause Resistance to Sotorasib KRAS G12C+ CRC Combo

May 31st 2025

More News